Literature DB >> 24295672

Potential modulation on P-glycoprotein and CYP3A by soymilk and miso: in vivo and ex-vivo studies.

C P Yu1, Y W Hsieh, S P Lin, Y C Chi, P Hariharan, P D L Chao, Y C Hou.   

Abstract

P-glycoprotein (P-gp) and CYP3A4 both play very important roles in drug bioavailability, resistance and interactions. Our in vitro studies indicated that P-gp function was activated by many isoflavones. This study investigated the in vivo effects of soymilk and miso, isoflavone-rich soy foods, on P-gp and CYP3A by tracing the pharmacokinetics of cyclosporine (CSP), a probe drug of P-gp. Rats were orally administered CSP with and without soymilk or miso. A specific monoclonal fluorescence polarisation immunoassay was used to determine the blood concentration of CSP. The results showed that soymilk and miso significantly decreased the C(max) of CSP by 64.5% and 78.3%, and reduced the AUC(0-540) by 64.9% and 78.3%, respectively. Mechanism studies revealed that the activities of P-gp and CYP3A4 were induced by soymilk and miso. In conclusion, ingestion of soymilk and miso significantly activated the functions of P-gp and CYP3A.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CYP3A; Cyclosporine; Miso; P-gp; Soymilk powders

Mesh:

Substances:

Year:  2013        PMID: 24295672     DOI: 10.1016/j.foodchem.2013.10.058

Source DB:  PubMed          Journal:  Food Chem        ISSN: 0308-8146            Impact factor:   7.514


  4 in total

Review 1.  Relevance of P-glycoprotein in stroke prevention with dabigatran, rivaroxaban, and apixaban.

Authors:  C Stöllberger; J Finsterer
Journal:  Herz       Date:  2015-01-25       Impact factor: 1.443

2.  A Systematic Review of Drug Metabolism Studies of Plants With Anticancer Properties: Approaches Applied and Limitations.

Authors:  Artitaya Thiengsusuk; Kanyarat Boonprasert; Kesara Na-Bangchang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-04       Impact factor: 2.441

3.  Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.

Authors:  Yow-Wen Hsieh; Ching-Ya Huang; Shih-Ying Yang; Yu-Hsuan Peng; Chung-Ping Yu; Pei-Dawn Lee Chao; Yu-Chi Hou
Journal:  Sci Rep       Date:  2014-10-10       Impact factor: 4.379

Review 4.  ABCB1 in dermatology: roles in skin diseases and their treatment.

Authors:  H J Weng; T F Tsai
Journal:  J Mol Med (Berl)       Date:  2021-08-09       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.